Latest filing published 10 Jul 2026 for RIGEL PHARMACEUTICALS INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Alison L. Hannah is a declared insider at 3 companies (senior executive); the most frequent names are Rigel Pharmaceuticals Inc, Neogenomics Inc and CytomX Therapeutics, Inc. Between 19 May 2021 and 8 July 2026, the trades on record add up to 13 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 10 July 2026, the filings show a share grant in Rigel Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations